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Abstract 
Background: Depression symptom screening scales are often used to determine a clinical 
diagnosis of major depressive disorder (MDD) in prevention research. The aim of this review 
is to systematically examine the reliability, validity and diagnostic utility of commonly used 
screening scales in depression prevention research among children and adolescents.  
Methods: We conducted a systematic review of the electronic databases PsycINFO, 
PsycEXTRA and Medline examining the reliability, validity and diagnostic utility of four 
commonly used depression symptom rating scales among children and adolescents: the 
Children's Depression Inventory (CDI), Beck Depression Inventory (BDI), Center for 
Epidemiologic Studies - Depression Scale (CES-D) and the Reynolds Adolescent Depression 
Scale (RADS). We used univariate and bivariate random effects models to pool data and 
conducted metaregression to identify and explain causes of heterogeneity. 
Results: We identified 54 studies (66 data points, 34,542 participants). Across the four 
scales, internal reliability was 'good' (pooled estimate: 0.89, 95% Confidence Interval (CI): 
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0.86 to 0.92). Sensitivity and specificity were 'moderate' (sensitivity: 0.80, 95% CI: 0.76 to 
0.84; specificity: 0.78, 95% CI: 0.74 to 0.83). For studies that used a diagnostic interview to 
determine a diagnosis of MDD, positive predictive power for identifying true cases was 
mostly poor. Psychometric properties did not differ on the basis of study quality, sample type 
(clinical vs. nonclinical) or sample age (child vs. adolescent).  
Limitations: Some analyses may have been underpowered to identify conditions in which 
test performance may vary, due to low numbers of studies with adequate data.  
Conclusions: Commonly used depression symptom rating scales are reliable measures of 
depressive symptoms among adolescents; however, using cutoff scores to indicate clinical 
levels of depression may result in many false positives. 
Keywords: Depression, Children, & Adolescents, Psychometrics, Validity, Psychiatric 
Symptom Rating Scales, Prevention.  
Abbreviations: 
ADIS-C: Anxiety Disorders Interview Schedule for Children  
AUC: Area under the curve 
BDI: Beck Depression Inventory 
BSI: Brief Symptom Inventory 
BYI: Beck Youth Inventories 
CBCL: the Child Behaviour Checklist  
CDI: Children’s Depression Inventory 
CDRS-R: Children’s Depression Rating Scale – Revised  
CES-D: Center for Epidemiologic Studies- Depression Scale 
CES-DC: Center for Epidemiologic Studies – Depression Scale for Children 
CIDI: Composite International Diagnostic Interview 
DAWBA: The Development and Wellbeing Assessment 
DEPS-10: Depression Scale - Version 10 
DICA-IV: Diagnostic Interview for Children and Adolescents- Version 4 
DISC: The National Institute of Mental Health Diagnostic Interview Schedule for Children 
DSM: Diagnostic and Statistical Manual 
DSRS: Depression Symptom Rating Scale (DSRS) 
HADS: Hospital Anxiety and Depression Scale 
ICD: International Classification of Diseases 
KID-SCID: Structured Clinical Interview for DSM-IV disorders – Child version 
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Kinder DIPS: Diagnostisches Interview bei psychischen Störungen im Kindes- und 
Jugendalter [German] 
K-SADS: Kiddie-Schedule for Affective Disorders and Schizophrenia 
MDD: Major depressive disorder 
MDI-C: Multi-score Depression Inventory- Children  
MINI: Mini-International Neuropsychiatric Interview 
MINI-KID: The Mini-International Neuropsychiatric Interview for Children 
NPV: Negative predictive value 
PPV: Positive predictive value 
PRIME-MD: The Primary Care Evaluation of Mental Disorders 
RADS: Reynolds Adolescent Depression Inventory  
RCDAS: Revised Child Anxiety and Depression Scale 
ROC: Receiver operator characteristic 
SBB-DES: The Self-Report Questionnaire—Depression [German]  
SCAN: Schedules for Clinical Assessment in Neuropsychiatry 
SCID: Structured Clinical Interview for Depression for DSM disorders  
SCID-1: Structured Clinical Interview for DSM-IV Axis I disorders 
SDQ: Strengths and Difficulties Questionnaire  
SMFQ: Short Mood and Feelings Questionnaire 
YSR: Youth Self-Report 
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Introduction 
Major depressive disorder (MDD) is the leading global cause of disability among 
young people aged 10-24 years, accounting for 8.2% of the global non-fatal disease burden 
(Gore et al., 2011). Approximately 3% of children and 6% of adolescents suffer current or 
recent depression (Costello et al., 2006). MDD in young people is associated with poor 
academic performance, substance abuse, attempted and completed suicide and an increased 
risk of suffering depression during adulthood (Birmaher et al., 1996, Brent et al., 1986). 
Despite the significant health burden associated with MDD, studies have suggested that less 
than 50% of youths seek mental health treatment for the condition (Reavley et al., 2010, Leaf 
et al., 1996). Valid and accurate screening tools for depression may assist clinicians in 
identifying MDD in youths, and may subsequently increase the rates of appropriate treatment 
and referral (Hosman et al., 2005, Andrews et al., 2002).  
Given the significant health burden associated with MDD, there has been growing 
recognition of the need to develop programs aiming to prevent the onset of MDD during 
childhood and adolescence (Hosman et al., 2005, Andrews et al., 2002). Promisingly, the 
number of studies that have examined the efficacy of preventative interventions for MDD 
among children and adolescents more than doubled between 2004 and 2010 (Merry et al., 
2004, Merry et al., 2011). Such interventions have typically been delivered in the school 
setting during regular classes by teachers or trained external facilitators (Merry et al., 2011). 
Given that routinely administering structured or semi-structured diagnostic interviews in 
schools can be costly and time consuming, many trials have used categorical thresholds on 
MDD symptom screening scales, such as the Center for Epidemiologic Studies – Depression 
Scale (CES-D) (Radloff, 1977) as a proxy for a diagnosis of MDD (Merry et al., 2011). 
Evaluating the efficacy of preventative interventions using symptom screening scales is 
problematic in two ways. Firstly, symptom screening scales that impose a categorical 
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threshold over a larger number of symptoms that are included in the DSM and the ICD can 
increase the number of cases that are identified compared to the cases where DSM or ICD 
diagnoses were applied (Ferrari et al., 2013).   
Secondly, while the reliability, validity and utility of identifying cases of MDD using 
the CES-D and other symptom screening scales have been established in adult populations 
(Radloff, 1977), the same clinical thresholds have been applied among childhood and 
adolescent samples. No review has systematically examined whether the clinical thresholds 
identified in adult samples are reliable, valid or useful for identifying cases of MDD among 
children and adolescents. There is also no review that has quantitatively synthesized the 
traditional psychometric properties of symptom screeners for MDD among children and 
adolescents. Indeed, previous reviews examining the traditional psychometric characteristics 
of depression symptom screening scales among children and adolescents have been non-
systematic and qualitative in nature, the most comprehensive of which were conducted more 
than a decade ago (Myers and Winters, 2002b, Brooks and Kutcher, 2001). The absence of 
robust data in support of applying the adult-derived thresholds for MDD when assessing for 
MDD among children and adolescents means that it is difficult to interpret the efficacy, 
effectiveness and efficiency of early-life preventative interventions for MDD meaningfully.  
The purpose of this review is to systematically: 1) identify symptom screening scales 
that are commonly used in childhood and adolescent preventative interventions for MDD; 
and 2) identify evidence of reliability, validity and diagnostic utility of these symptom 
screening scales.  
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Methods 
Search 1: Identify symptom screening scales that are commonly used in childhood and 
adolescent preventative interventions for MDD. 
a) Search strategy 
Given the large number of randomized controlled trials examining the efficacy of preventive 
interventions for MDD among children and adolescents, and the existence of multiple 
reviews synthesizing these findings (e.g. (Merry et al., 2004, Merry et al., 2011)), we 
conducted a systematic review of reviews, and updated recent reviews with any studies which 
may have been published subsequent to their publication date. The review of reviews was 
conducted in August, 2013 using the online databases PubMed, Medline, PSYCINFO and the 
Cochrane Library of Systematic Reviews, in consultation with a librarian and in accordance 
with the Preferred Reporting Items for Systematic Reviews and Meta Analyses (PRISMA) 
statement (Liberati et al., 2009). Databases were searched using a combination of MeSH 
terms and text words pertaining to depression and dysthymia (Depressive Disorder, Major 
Depression, Dysthymic Disorder, “dysthymia.mp.”), prevention (Primary Prevention, 
Preventative Psychiatry, “prevention.mp.”) and intervention trials (Intervention Studies, 
“intervention.mp.”). An additional search of empirical studies dated from August 2010-
present was conducted in January 2014 to identify recently published randomised controlled 
trials not included in the existing reviews. This additional search was conducted in the 
electronic databases PubMed, Medline and PSYCINFO using the search string ((((depress* 
OR dysthymi*)) AND (child* OR adolescen*)) AND (prevent* OR early intervention* OR 
risk OR at-risk OR vulnerab*)) AND (randomised controlled trial OR controlled trial 
[Publication Type]).  
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b) Inclusion criteria 
i) Reviews: Reviews were eligible for inclusion if: 1) they were published 
between 2003 and August 2013 in the English language; 2) the authors 
employed systematic methods of reviewing the literature; and 3) the data were 
reported in a usable form, and:  
ii) Empirical studies: Individual studies identified within the reviews, and the 
updated search of empirical studies were eligible for inclusion if: 4) the 
participants were aged between 5 and 18 years; 5) participants were randomly 
assigned to an intervention or a control group; 6) the control group received no 
intervention, placebo or usual care; and 7) the intervention aimed to prevent of 
the onset of depression or dysthymia. 
c) Data extraction 
Data were extracted from each empirical study by co-author ES and were cleaned and double 
checked by co-author YL and included: 1) sociodemographics of the sample; 2) details of the 
intervention and delivery; 3) timing of follow-up assessments; 4) the methods used to 
measure the prevalence, or symptoms of depression or dysthymia, including depression 
symptom screening scales, or structured diagnostic interviews; and 5) outcome data. 
Symptom screening scales were defined as any type of measure that provided an assessment 
of MDD, producing a numerical score that has guidelines for interpretation, whether 
completed by the person of interest (self report) or someone else (e.g. parent, guardian, 
teacher), with any type of response format (Myers and Winters, 2002a). For the purposes of 
this review, depression symptom screening scales were defined as ‘common’ if they were 
used in more than two studies. Scales used in less than two studies are mentioned only briefly 
here. 
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Search 2: Identify evidence of reliability, validity and diagnostic utility of commonly used 
depression symptom screening scales used in childhood and adolescent preventative 
interventions for MDD. 
a) Search strategy 
For each symptom screening scale for MDD that was identified as commonly used in Search 
1, evidence for each scale’s reliability, validity and diagnostic utility in any child or 
adolescent sample (not limited to samples where preventive interventions were applied) was 
obtained through a series of additional systematic searches of the literature using PsycINFO, 
PsycEXTRA and Medline and a combination of MeSH terms and text words pertaining to 
depression (exp Major Depression), children (children OR adolesc~) symptom screening 
scales (exp Rating scales/exp Screening Tests/exp Psychological Tests/exp Psychiatric Status 
Rating scales), and psychometric properties (exp Psychometrics/exp Test Validity/exp Test 
Reliability/exp Diagnostic Utility), and the name of each individual scale as text words (e.g 
“children’s depression inventory”, “center for epidemiologic studies depression scale”, “beck 
depression inventory”,). Other sources of literature included existing reviews of depression 
scales (Brooks and Kutcher, 2001, Brooks and Kutcher, 2003, Pavuluri and Birmaher, 2004, 
Suzuki, 2011, Collett et al., 2003), and hand searches of articles identified as relevant.  
 
b) Eligibility criteria 
Articles reporting on the scales’ reliability, validity and diagnostic utility were eligible for 
inclusion in the review if the study was: 1) published between 1980 (following publication of 
the initial validation studies) and August 2013 in the English language; 2) the participants 
were aged between 5 and 18 years; 3) the scale was identified in Search 1; and 4) the study 
reported the traditional psychometric properties of the scale including measures of reliability 
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and/or validity. We excluded any revisions or short versions of the scales if they were not 
analogous to the original scales (i.e. differed in terms of number of items, scoring method, 
etc.). Studies attempting to translate an existing scale into another language without reporting 
psychometric properties of the scale itself were excluded.  
 
c) Data extraction 
Data from each included study were extracted by co-author AL and were cleaned and double 
checked by co-author ES and included: 1) characteristics of the sample (including sample 
size, age, gender, country, language and setting); 2)  the names of the scales assessed and the 
number of items; 3) the test-retest and inter-rater reliability of the scale; 4) the internal 
validity of the scale (e.g. Cronbach’s alpha); 5) details about the external validity of the scale 
including the categorical thresholds used to indicate cases of MDD, the type of clinical 
interview used to determine cases of MDD  (i.e. the ‘criterion standard’), and the associated 
sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and 
area under the curve (AUC) results derived from receiver operating characteristics (ROC) 
analyses (described below). Sensitivity, specificity, PPV and NPV were calculated manually 
when data were partially reported, and could be imputed based on the presentation of other 
data. 
 
Primary outcomes: Traditional psychometric properties and diagnostic utility  
a) Data synthesis  
Data were synthesised via meta analysis using the statistical software program Stata/SE 
version 13.1 (StataCorp, 2013). We used univariate random effects models to pool data 
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across all studies for the primary outcomes internal reliability and AUC. Bivariate random 
effects models (using the ‘mvmeta’ command) were used to pool data for the primary 
outcomes sensitivity and specificity in order to take into account the interdependency of these 
values. Values for PPV and NPV were not meta analysed and were synthesised in a 
qualitative manner only, as these values are highly dependent on the prevalence of depression 
in each sample, which was likely to vary substantially between each study included in this 
review (Leeflang et al., 2012). In order to identify and explain any causes of heterogeneity, 
random effects metaregression (using the ‘metareg’ command) was performed on the primary 
outcomes (with the exception of PPV and NPV) for each of the four scales, and across the 
four scales overall. The effects of the sample setting (clinical vs. nonclinical), age (children 
vs. adolescents), risk of bias quality score, the cutoff score used, and the scale (CDI, BDI, 
CES-D, RADS) were evaluated by individually adding them as covariates in the regression 
models. Due to the small number of studies, these analyses were primarily exploratory.  
Additionally, the I2 index was employed to quantify any heterogeneity in the pooled 
estimates, and was described as low, moderate or high according to an I2 value of 25, 50 and 
75%, respectively (Higgins et al., 2003). Statistical significance for all analyses was set at p < 
.05.  
 
b) Reliability 
The internal consistency of each scale was assessed using Cronbach’s alpha [α], and test 
retest and interrater reliability were assessed using the Kappa [κ] statistic. These reliability 
coefficients were classified as ‘excellent’ if α ≥ .9, ‘good’ if .85 ≤ α < .9, ‘moderate’ if .80 ≤ 
α < .85, ‘fair’ if .75 ≤ α < .80, or ‘unsatisfactory’ if < .75 (Ponterotto and Ruckdeschel, 2007).  
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c) Validity  
To examine the validity of each scale, we assessed five key measures of discriminative 
validity: 1) sensitivity (the proportion of true cases correctly identified, or “true positive 
rate”); 2) specificity (proportion of non-cases correctly identified, or “true negative rate”); 3) 
PPV (probability that subjects identified as cases are true cases, or “precision”); and 4) NPV 
(probability that the subjects identified as not being a case are not cases) (Murphy and 
Davidshofer, 1994). For inclusion of studies in the meta analysis, we assigned a minimum 
quality assessment for the criterion standard as diagnoses made using either a standardised 
(e.g. the Composite International Diagnostic Interview (CIDI)) or structured (e.g. Kiddie-
Schedule for Affective Disorders and Schizophrenia (K-SADS)) diagnostic interview 
schedule based on DSM or ICD-10 diagnostic criteria. Clinician rated diagnoses without 
reference to a specific diagnostic instrument were excluded from the analyses. Based on 
expert statistical recommendation, we assigned a value of ‘excellent’ for the  scales’ 
sensitivity, specificity, PPV and NPV if the pooled value of coefficient across studies was ≥ 
.9, a value of ‘good’ if .8 ≤ coefficient < .9, a value of ‘moderate’ if 0.6 ≤ coefficient < 0.8, 
and a value of ‘low’ coefficient < .6 (Andrews et al., 1993). We additionally assessed the 
scale’s diagnostic accuracy using the area under the curve (AUC) receiver operating 
characteristic (ROC) analysis. ROC curves plot the tradeoff between sensitivity and 
specificity values for all possible cutoff scores, and the AUC is a measure of the scales’ 
overall ability to correctly classify individuals as cases or noncases (Brooks and Kutcher, 
2001). This is calculated as the sum of true positives and the sum of true negatives divided by 
the total population (not taking into account false positive or negatives). AUC values range 
from 0.5 (random classification) to 1 (perfect classification). Henderson (Henderson, 1993) 
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recommended the following interpretation with respect to the scales’ diagnostic accuracy: 
AUC > 9 ‘high’; 0.7 < AUC ≤ 0.9 ‘moderate’; AUC ≤ 7 ‘low’.  
Risk of bias  
Risk of bias in the included studies was examined using the risk assessment tool developed 
by the Cochrane Collaboration Diagnostic Test Accuracy Working Group (Reitsma et al., 
2009), derived from the Revised Quality Assessment of Diagnostic Accuracy Studies 
(QUADAS-2) tool (Whiting et al., 2011b). Risk was determined across four domains: patient 
selection, index test, reference standard, and flow and timing, and was categorised and 
quantified as either low (3), unclear (2) or high (1) in order to derive a total quality score for 
use in the metaregression analyses. 
 
Results 
Search 1: Identify commonly used depression symptom screening scales in childhood and 
adolescent preventative interventions for MDD. 
Search 1 identified 17 systematic reviews of childhood and adolescent preventative 
interventions for MDD. These 17 reviews contained a total of 394 individual trials, of which 
288 were duplicates (in instances where the same trial appeared in more than one review) and 
106 were unique.  
Of the 106 unique trials, 103 assessed depressive symptomatology as an outcome using 
depression symptom screening scales, and 32 assessed the prevalence of MDD using either 
cutoff scores on depression symptom screening scales (n = 15) or by administering structured 
or semistructured clinical interviews (n = 17). Across the 103 trials, a total of 17 different 
depression symptom screening scales, and five structured or semistructured clinical 
interviews were used. The most commonly used screening scale for assessing depressive 
13 
 
symptomatology was the Children’s Depression Inventory (CDI; 45 studies), followed by the 
Beck Depression Inventory (BDI; 16 studies), the Center for Epidemiologic Studies – 
Depression Scale (CES-D; 15 studies), and the Reynolds Adolescent Depression Scale 
(RADS; 5 studies). The following scales were used as outcome measures in two studies or 
fewer: the Brief Symptom Inventory (BSI), the Child Behaviour Checklist (CBCL), the 
Children’s Depression Rating Scale – Revised (CDRS-R), the Depression Symptom Rating 
Scale (DSRS), Beck Youth Inventories (BYI), the Depression Scale version 10 [Finnish] 
(DEPS-10), the Hospital Anxiety and Depression Scale (HADS), the Multi-score Depression 
Inventory – Children (MDI-C), the Revised Child Anxiety and Depression Scale (RCADS), 
Youth Self-Report (YSR), and The Self-Report Questionnaire—Depression [German] 
(Selbstbeurteilungsbogen—Depressive Störungen; SBB–DES). Two studies were found to 
have used undefined composite constructs. The most commonly used measure to determine 
the presence of MDD was the Kiddie-Schedule for Affective Disorders and Schizophrenia 
(K-SADS; 7 studies), followed by the Anxiety Disorders Interview Schedule for Children 
(ADIS-C; 5 studies), the Diagnostic Interview for Children and Adolescents version 4, 
(DICA-IV; 1 study), and the Structured Clinical Interview for Depression for DSM disorders 
(SCID; 1 study).  
 
Search 2: Identify evidence of reliability, validity and diagnostic utility of commonly used 
depression symptom screening scales used in childhood and adolescent preventative 
interventions for MDD. 
Figure 1 shows the study selection process. The search for the reliability, validity and 
diagnostic utility of depression symptom screening scales for children and adolescents 
yielded a total of 2017 results, of which 1798 were unique. Of these, 1626 were excluded as 
they were not relevant to the topic. Of the remaining 172 publications, 77 were excluded as 
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the age of the sample was outside the specified age range (5-18), 30 conducted unrelated 
psychometric tests, 10 assessed the validity of translated versions only and 3 assessed short or 
alternate versions of the target scale. We identified the remaining 52 papers (comprising 54 
studies) as relevant, of which 21 assessed the reliability, validity and diagnostic utility of the 
CDI, 17 examined the BDI (one study additionally examined the CES-D, and study 
additionally examined the RADS), 10 examined the CES-D and 6 examined the RADS 
(Figure 1). The 54 studies comprised a total of 66 individual data points and 34,542 
participants. Studies were conducted predominantly in the United States, with a minority 
conducted in Europe (Spain, Germany, Belgium, Denmark, the Netherlands, Greece, Sweden 
and Switzerland), Africa (Nigeria and Rwanda), India and Taiwan. Half of the articles 
included in this review (n = 26 articles, 32 studies; 50%) were published since the last major 
review of symptom screening scales for MDD among children and adolescents in 2002 
(Myers and Winters, 2002b).  
 
Risk of bias in included studies 
Of the 52 individual papers (based on 54 studies) included in the review, risk of bias was 
mostly unable to be determined, or determined to be high (Figure 1a, online supplement). 
Only 10 studies employed representative samples. Four studies pre-specified the cutoff scores 
on the scales to determine ‘caseness’, with most studies calculating these values post-hoc (n = 
39). Of the 33 studies that used a diagnostic interview to determine the discriminative validity 
of the symptom screening scale, 24 used structured or semistructured clinical interviews 
based on ICD-10 or DSM criteria, however only 14 of these stated that the interviewers were 
blinded to the scale scores when administering the interview. The 9 studies that used 
undefined clinical interviews that were not based on ICD-10 or DSM diagnostic criteria were 
excluded from the analyses. Appropriate lag time between the index test (symptom screening 
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scale) and reference test (diagnostic interview) was deemed to be within one week (Whiting 
et al., 2011a), and 11 studies fulfilled this criterion.  
 
Commonly used depression scales for children and adolescents  
Children’s Depression Inventory (CDI) 
The CDI is the child version of Beck Depression Inventory (BDI), designed for use with 
children aged 7-18 years (Kovacs, 1984). The scale is self report, comprises 27 items with 
three-point answers and takes approximately 10-20 minutes to complete and score (Kovacs, 
1984). The period of assessment is the prior two weeks, and the range of possible scores is 0 
to 54. The CDI was specifically designed for and tested among children and adolescents and 
includes a corresponding parent version. It has a good track record in depression research as 
it is one of the most widely used and studied scale of youth depression, with normative data 
available for children and adolescents (Kovacs, 1984). The CDI purports to possess a five 
factor structure, however one of the factors relates to externalising disorders (‘acting out’) 
and one to anxiety, resulting in uncertainty around the validity of depression construct (Myers 
and Winters, 2002b).  
Reliability, validity and diagnostic utility coefficients for the CDI among clinical and 
nonclinical samples nonclinicalof children and adolescents identified in our review are 
summarised in Table 1, and Figure 2. The 21 identified studies comprised a total of 25 data 
points (n = 8371). Of these, 14 studies (18 data points) provided details of the scales’ internal 
reliability (Allgaier et al., 2012, Carey et al., 1987, Crowley and Emerson, 1996, Crowley et 
al., 1994, Figueras Masip et al., 2010, Fundudis et al., 1991, Giannakopoulos et al., 2009, 
Nelson III et al., 1987, Reynolds et al., 1985, Saylor et al., 1984, Smucker et al., 1986, 
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Sorensen et al., 2005, Thompson et al., 2012, Weiss et al., 1991). The pooled estimate for 
internal reliability was 0.86 (18 data points, n = 7372, 95% confidence interval (CI): 0.84 to 
0.88) and was classified as ‘good’ (Figure 2), however heterogeneity was high (I2 = 76%). 
Metaregression showed that sample type (clinical vs. nonclinical; t(1, 15) = 0.50, p = 0.62, 
adjusted R2 <0), sample age (child vs adolescent; t(1,15) = 0.31, p = 0.76, R2 <0) and risk of 
bias quality score (t(1, 15) = 1.61, p = 0.13, R2 = 67.38%) did not significantly affect the 
internal reliability values on the CDI.  
Nine studies (10 data points) examined the discriminative validity of the CDI (Allgaier et al., 
2012, Figueras Masip et al., 2010, Fristad et al., 1988, Fundudis et al., 1991, Roelofs et al., 
2010, Shemesh et al., 2005, Timbremont et al., 2004, Sorensen et al., 2005, Craighead et al., 
1995) with cutoff scores ranging from 11 to 19 (M = 14.5, SD = 2.67). Of these, seven used 
structured or semi structured clinical interviews to determine presence of MDD. All seven 
studies examined the specificity and sensitivity of the CDI. Bivariate meta analyses revealed 
that sensitivity was ‘good’ overall (7 data points, n = 1432, pooled estimate: 0.83, 95% CI: 
0.77 to 0.89), as was specificity (7 data points, n = 1432, pooled estimate: 0.84, 95% CI: 0.77 
to 0.92), however heterogeneity was high (I2 = 91% and 96% respectively). Metaregression 
showed that the sample type (clinical vs. nonclinical; t(1, 6) = 0.59, p = 0.58, R2 < 0), sample 
age (child vs adolescent; t(1, 6)= 1.05, p = 0.33, R2 < 0), cutpoint used (t (1, 6) = 2.21, p = 
0.06, R2 = 38.68%) and risk of bias quality score (t (1, 6) = 0.56, p  = 0.59, R2 < 0) did not 
significantly affect sensitivity values on the CDI. Six studies examined the PPV of the CDI, 
all of which were conducted among clinical samples, and most were classified as ‘low’, with 
values of 0.28 (Allgaier et al., 2012), 0.35 (Roelofs et al., 2010), 0.38 (Shemesh et al., 2005), 
0.21 (Sorensen et al., 2005), 0.63 (Timbremont et al., 2004) and 0.90 (Fristad et al., 1988).  
Five studies examined the NPV of the CDI, and as per the PPV values, all were conducted 
among clinical samples. NPV values were mostly classified as ‘excellent’,  with values of 1.0 
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(Roelofs et al., 2010), 0.98 (Allgaier et al., 2012), , 0.98 (Timbremont et al., 2004), 0.94 
(Shemesh et al., 2005) and 0.63 (Sorensen et al., 2005).  Four studies examined the diagnostic 
accuracy of the CDI using AUC analyses, all of which were conducted among clinical 
samples (Allgaier et al., 2012, Roelofs et al., 2010, Sorensen et al., 2005, Timbremont et al., 
2004), and overall accuracy was classified as ‘high’ (4 data points, n = 1146, pooled estimate: 
0.90, 95% CI: 0.79 to 0.98; Figure 2), however heterogeneity was high I2=95%. There was 
insufficient data to conduct a metaregression on AUC values for the CDI.  
 
Beck Depression Inventory (BDI) 
The BDI was originally developed in 1961 as a depression symptom rating scale for the adult 
population (Beck and Alford, 2009). The original inventory comprises 21 items, with four (or 
five) statement responses representing how the respondent has been feeling during the past 
week and current day. The statements are presented in order of increasing severity and are 
scored from 0 to 3 (alternative statements sharing the same score are sometimes provided). 
Six of the items refer to vegetative symptoms; the remaining 15 items refer to either affective 
or cognitive symptoms. The range of possible scores is 0 to 63 (Beck et al., 1961). The scale 
is widely used among both adults and adolescents and has a strong track record in depression 
research (Myers and Winters, 2002b). The scale lacks items pertaining to school and does not 
offer parallel parent or teacher rating forms, and as such, its use among younger children may 
not be suitable (Kovacs and Beck, 1977). There are several alternate versions of the BDI. The 
BDI-1A is a revision of the original BDI (Beck et al., 1996), also containing 21 items but 
with refined response formats and a defined assessment period of the prior two weeks. The 21 
item BDI-II is a further revision of the BDI, developed in 1996 to align with the DSM-IV 
criteria for depression (Beck et al., 1996).  
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Reliability, validity and diagnostic utility coefficients for the BDI among clinical and 
nonclinical samples of children and adolescents are summarised in Table 2 and Figure 3. The 
17 identified studies comprised a total of 20 data points (n = 5464). Of these, 11 studies (12 
data points) examined the scale’s internal reliability (Adewuya et al., 2007, Ambrosini et al., 
1991, Barrera and Garrison-Jones, 1988, Dolle et al., 2012, Jolly et al., 1994, Krefetz et al., 
2002, Kumar et al., 2002, Roberts et al., 1991, Strober et al., 1981, Teri, 1982, Kashani et al., 
1990). The pooled estimate for internal reliability was 0.86 (12 data points, n = 4152, 95% 
CI: 0.81 to 0.90) and was classified as ‘good’, and heterogeneity was moderate (I2 = 72%) 
(Figure 3). Metaregression showed that sample type (clinical vs. nonclinical; t (1, 9) = 1.86, p 
= 0.09, R2 = 32.17%), sample age (child vs adolescent; t (1, 9) = 0.88, p = 0.40, R2 = 73.52%) 
and risk of bias quality score (t (1, 9) = 0.70, p = 0.50, R2 < 0) did not significantly affect the 
internal reliability values on the BDI.  
Fifteen studies (18 data points) examined the discriminative validity of the BDI (Adewuya et 
al., 2007, Ambrosini et al., 1991, Barrera and Garrison-Jones, 1988, Bennett et al., 1997, 
Blom et al., 2010, Canals et al., 2001, Dolle et al., 2012, Kashani et al., 1990, Krefetz et al., 
2002, Kumar et al., 2002, Marton et al., 1991, Roberts et al., 1991, Russell et al., 2012, 
Strober et al., 1981, Whitaker et al., 1990), with cutoff scores ranging from 11 to 24. Of the 
13 studies that used a structured or semi-structured clinical interview, 12 studies (13 data 
points) examined the scales’ sensitivity and specificity (Adewuya et al., 2007, Ambrosini et 
al., 1991, Barrera and Garrison-Jones, 1988, Bennett et al., 1997, Canals et al., 2001, Dolle et 
al., 2012, Kashani et al., 1990, Marton et al., 1991, Roberts et al., 1991, Russell et al., 2012, 
Strober et al., 1981, Whitaker et al., 1990). Bivariate meta analyses revealed that sensitivity 
was ‘good’ overall (13 data points, n = 4597, pooled estimate: 0.81, 95% CI: 0.74 to 0.87), as 
was specificity (13 data points, n = 4597, pooled estimate: 0.81, 95% CI: 0.75 to 0.88; Figure 
3), however heterogeneity was high (I2 = 94% and 97% respectively). Metaregression showed 
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that the sample type (clinical vs. nonclinical; t(1, 12) = 0.73, p = 0.48, R2  < 0), sample age 
(child vs adolescent; t(1, 12) = 0.85, p = 0.41, R2 < 0), cutpoint used  (t(1, 12) = 0.13, p = 
0.90, R2 < 0) and risk of bias quality score (t(1, 12) = 1.32, p = 0.37, R2 = 28.33%) did not 
significantly affect sensitivity values on the BDI. Similar results were found for specificity, 
with no impact of sample type (t(1, 12) = 0.86, p = 0.40, R2 < 0), age (t(1, 12) = 0.83, p = 
0.42, R2 < 0), cutpoint used (t(1, 12) = 0.94, p = 0.37, R2 < 0) or risk of bias quality score (t(1, 
12) = 0.39, p = 0.70, R2 < 0).  
Eight studies examined the PPV of the BDI, half of which were conducted with clinical 
samples and half in non-clinical samples, with significant heterogeneity between studies. 
PPV values were higher overall in clinical samples, with values of 0.79 (Marton et al., 1991), 
0.81 (Bennett et al., 1997), 0.81 (Dolle et al., 2012), and 0.93 (Ambrosini et al., 1991) and 
were lower, however more varied in nonclinical samples, with values of 0.10 (Roberts et al., 
1991), 0.14 (Russell et al., 2012), 0.47 (Canals et al., 2001) and 0.88 (Adewuya et al., 2007) 
(Figure 3). Five studies examined the NPV of the BDI, with values of 0.80 (Bennett et al., 
1997), 0.95 (Dolle et al., 2012), 0.97 (Russell et al., 2012),  0.98 (Adewuya et al., 2007) 0.99 
(Canals et al., 2001) and 0.99  (Roberts et al., 1991) (Figure 3). Six studies (7 data points) 
used AUC analyses to examine the diagnostic accuracy of the BDI (Adewuya et al., 2007, 
Blom et al., 2010, Dolle et al., 2012, Kashani et al., 1990, Roberts et al., 1991, Russell et al., 
2012), and overall accuracy was classified as ‘high’ (7 data points, n = 3249, pooled 
estimate: 0.92, 95% CI: 0.81 to 1.00). Metaregression showed that the sample type (clinical 
vs. nonclinical; t(1, 6) = 0.39, p = 0.71, R2 < 0), sample age (child vs adolescent; t(1, 6) = 
0.09, p = 0.93, R2  <0), cutpoint used  (t(1, 6) = 0.17, p = 0.87, R2  < 0) and risk of bias quality 
score (t(1, 6) = 1.44, p = 0.19, R2  = 14.16%) did not significantly affect AUC values on the 
BDI. 
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Center for Epidemiologic Studies Depression Scale (CES-D) 
The CES-D is a 20-item self-report questionnaire designed to detect depression in the general 
population. The items address six symptom areas of depression including depressed mood, 
feelings of guilt/worthlessness, helplessness, psychomotor retardation, loss of appetite and 
sleep disturbance (Radloff, 1977). Each of the 20 items is rated on a scale from 0 to 3, with 
total scores ranging from 0-60. The period of assessment is the past week. The CES-DC is the 
child version of the original CES-D and retains the same number of items and response 
format; however language has been adjusted to suit a child reading level (Weissman et al., 
1980).  
Reliability, validity and diagnostic utility coefficients for the CES-D among clinical and 
nonclinical samples of children and adolescents are summarised in Table 3 and Figure 4. 
Nine studies (10 data points) examined the internal reliability of the original full scale CES-D 
(Aebi et al., 2009, Betancourt et al., 2012, Cuijpers et al., 2008, Fendrich et al., 1990, 
Garrison et al., 1991, Logsdon and Myers, 2010, Roberts et al., 1991, Thrane et al., 2004). 
The pooled estimate for internal reliability was 0.88 (10 data points, n = 9006, 95% CI: 0.84 
to 0.92, Figure 4) was classified as ‘good’, however heterogeneity was high (I2 = 92%). 
Metaregression showed that sample type (clinical vs. nonclinical; t(1, 7) = 0.87, p = 0.41, R2 
< 0), sample age (child vs adolescent; t(1, 7) = 0.79, p = 0.45, R2  = 2.75%) and risk of bias 
quality score (t(1, 7) = 0.44, p = 0.67, R2 < 0) did not significantly affect the internal 
reliability values on the CES-D.  
 
Nine studies (12 data points) examined the discriminative ability of the CES-D (Aebi et al., 
2009, Betancourt et al., 2012, Cuijpers et al., 2008, Fendrich et al., 1990, Garrison et al., 
1991, Logsdon and Myers, 2010, Prescott et al., 1998, Roberts et al., 1991, Yang et al., 
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2004), with cutoff scores ranging from 12 to 24. Of these, eight studies used structured or 
semi structured clinical interviews to determine a diagnosis of depression. Bivariate meta 
analysis revealed that sensitivity coefficients were ‘moderate’ overall (9 data points, n = 
9209, pooled estimate: 0.76, 95% CI: 0.67 to 0.84) as was specificity (9 data points, n = 
9209, pooled estimate: 0.71, 95% CI: 0.63 to 0.79). Metaregression showed that sample type 
(clinical vs. nonclinical; t(1, 7) = 0.08, p = 0.93, R2 < 0), sample age (child vs adolescent; t(1, 
7) = 0.80, p = 0.45, R2 < 0) risk of bias quality score (t(1, 7) = 1.71, p = 0.13, R2 = 18.04%) 
and cutpoint used (t (1, 7) = 0.70, p = 0.51, R2  < 0) did not significantly affect the sensitivity 
values on the CES-D. Similar results were found for specificity, with no impact of sample 
type (t(1, 7) = 0.12, p = 0.91, R2 < 0), age (t(1, 7) = 1.36, p = 0.21, R2 = 12.69%), risk of bias 
quality score (t(1, 7) = 0.77, p = 0.46, R2 < 0) or cutpoint used (t(1, 7) = 2.12, p = 0.07, R2 = 
32.62%).  
Five studies (six data points) examined the PPV and NPV of the CES-D, with only one study 
conducted among a clinical sample (Logsdon and Myers, 2010), and the remainder in 
nonclinical samples (Fendrich et al., 1990, Garrison et al., 1991, Logsdon and Myers, 2010, 
Prescott et al., 1998, Roberts et al., 1991). PPV was low overall, with values of 0.08 (Roberts 
et al., 1991), 0.15 (Fendrich et al., 1990), 0.16 (Garrison et al., 1991), 0.24 (Prescott et al., 
1998), 0.25 (Logsdon and Myers, 2010) and 0.32 (Garrison et al., 1991). NPV was good 
overall (with the exception of the one study conducted among a clinical sample where NPV = 
0.12; (Logsdon and Myers, 2010)), and values were 0.96 (Fendrich et al., 1990, Prescott et 
al., 1998), 0.98 (Garrison et al., 1991) and 0.99 (Roberts et al., 1991). Seven studies (nine 
data points) examined diagnostic utility of the CES-D using AUC analyses (Betancourt et al., 
2012, Cuijpers et al., 2008, Garrison et al., 1991, Logsdon and Myers, 2010, Prescott et al., 
1998, Roberts et al., 1991, Yang et al., 2004), which was classified as ‘moderate’ overall (9 
data points, n = 8989, pooled estimate: 0.83, 95% CI: 0.74 to 0.90, I2 = 99%). Metaregression 
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revealed that studies using higher cutpoints on the CES-D had higher diagnostic accuracy 
(t(1, 8) = 5.1, p = 0.01, β = 1.01, R2 = 53.22%), with no significant effect found for sample 
type (clinical vs. nonclinical; t(1, 8) = 1.54, p = 0.17, R2 = 12.88% ), sample age (child vs. 
adolescent; t(1, 8) = 1.12, p = 0.30, R2  = 7.93%), and the risk of bias quality score (t(1, 8) = 
0.69, p = 0.51, R2 < 0).  
 
Reynolds Adolescent Depression Scale (RADS) 
The Reynolds Adolescent Depression Scale is a 30-item self report instrument developed in 
1986 to assess depression symptom severity in adolescents (13-18 years) (Reynolds, 1986). 
Responses are made on a four point scale indicating frequency (almost never, hardly ever, 
sometimes, most of the time) of symptoms characteristics of depression. The scale assesses 
cognitive, somatic, psychomotor, and interpersonal symptoms derived from the DSM-III, 
with an assessment period of the past two weeks. The RADS takes approximately 10 minutes 
to complete, and scores range from 30 to 120 (Walker et al., 2005a). The RADS-2 is an 
updated version of the original RADS. It also contains 30 items, and addresses several 
psychometric issues in the original RADS such as re-examining estimates of internal 
consistency, criterion related validity, and known groups validity (Osman et al., 2010).  
Scores across the reliability, validity and diagnostic utility for the RADS among clinical and 
nonclinical samples of children and adolescents are summarised in Table 4. Six studies (7 
data points) examined the internal reliability of the RADS (Boyd and Gullone, 1997, Krefetz 
et al., 2002, Osman et al., 2010, Reynolds and Miller, 1985, Walker et al., 2005b, Weber and 
Terhorst, 2010), which was classified as ‘excellent’ overall (7 data points, n = 11095, pooled 
estimate: 0.93, 95% CI: 0.86 to 0.99), however heterogeneity was high (I2 = 92%). 
Metaregression showed that sample type (clinical vs. nonclinical; t(1, 4) = 0.52,  p  = 0.62, R2 
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< 0), sample age (child vs adolescent; t(1, 4) = 1.10, p  = 0.32, R2 = 5.56% ) and risk of bias 
quality score (t(1, 4) = 0.66, p = 0.54, R2 < 0) did not significantly affect the internal 
reliability values on the RADS. 
Only two studies examined the discriminative validity of the full scale RADS (Krefetz et al., 
2002, Osman et al., 2010) using cutoff scores of 67 and 70, however neither study used a 
structured or semi-structured clinical interview based on DSM or ICD-10 criteria to 
determine a diagnosis of MDD, and thus meta analyses and metaregression for sensitivity, 
specificity and AUC values were not conducted.   
 
Overall judgement 
Comparisons across scales using metaregression revealed no differences in the four key 
measures of reliability and validity. Internal reliability was classified as ‘good’ overall (47 
data points, n = 31593, pooled estimate: 0.89, 95% CI: 0.86 to 0.92, I2 = 93%), with 
metaregression revealing no impact of scale type (CDI, BDI, CES-D, RADS; t(1, 44) = 2.54, 
p = 0.07, R2  = 15.31%).sample (clinical vs. nonclinical; t(1, 44) = 0.21, p = 0.84, R2 < 0), age 
(child vs. adolescent; t(1, 44) = 1.30, p = 0.20, R2 = 3.33%) or risk of bias quality score (t(1, 
44) = 0.05, p  = 0.96, R2 < 0). Sensitivity and specificity coefficients were ‘moderate’ 
(sensitivity: 29 data points, n = 15238, pooled estimate: 0.80, 95% CI: 0.76 to 0.84; 
specificity: 29 data points, n = 15238, pooled estimate: 0.78, 95% CI: 0.74 to 0.83), with  
metaregression revealing no impact of scale type (t(1, 29) = 1.36, p = 0.18, R2 = 3.06%), 
sample type (t(1, 29 = 1.24, p = 0.22, R2 = 1.53%) age (t(1, 29) = 1.25, p = 0.22, R2 = 1.60%) 
cutpoint (t(1, 29) = 0.55, p = 0.59, R2 < 0) or risk of bias quality score (t(1, 29) = 1.79, p = 
0.08, R2 = 6.54%  for sensitivity coefficients.  Similar results were found for specificity, with 
no difference on the basis of scale type (t(1, 29) = 1.65, p = 0.12, R2 = 16.12%) sample (t(1, 
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29) = 0.32, p = 0.75, R2 < 0), age (t(1, 29) = 1.23, p = 0.23, R2 = 1.41%), cutpoint (t(1, 29) = 
0.99. p = 0.33, R2 < 0) or risk of bias quality score (t (1, 29) = 0.25, p = 0.80, R2 < 0). Overall 
diagnostic accuracy was ‘moderate’ (20 data points, n = 13384, pooled estimate: 0.86, 95% 
CI: 0.79 to 0.92, I2 = 98%), with metaregression revealing no impact of scale type (t(1, 20) = 
1.52, p = 0.14, R2 =6.19%) , sample (t(1, 20) = 0.84, p = 0.81, R2 < 0) , age (t(1, 20) = 0.41, p 
= 0.68, R2 < 0) cutpoint (t(1, 20) = 0.25, p = 0.80, R2 < 0) or risk of bias quality score (t (1, 
20) = 0.97, p = 0.34, R2 < 0).   
 
Discussion 
This is the first systematic review and meta analysis to provide an objective judgement of the 
reliability, validity and diagnostic utility of symptom screening scales used in prevention 
research for MDD among children and adolescents. The review identified 54 studies 
(published in 52 papers), of which 32 studies were published since the last major narrative 
review was conducted in 2002 (Myers and Winters, 2002b). The outcomes of this review 
indicate that commonly used symptom screening scales for MDD including the CDI, BDI, 
CES-D and the RADS have good internal consistency when used among children and 
adolescents; and metaregression revealed that these properties did not differ when a range of 
factors were considered, including sample type (clinical vs. nonclinical), age (child vs. 
adolescent) and the risk of bias quality score. While the ability of each scale to correctly 
identify positive and negative cases (i.e. diagnostic utility) was moderate overall; positive 
predictive power was poor across most scales, suggesting that using cutoff scores on these 
scales to determine clinical levels of MDD may result in high misclassification rates, 
particularly when used in nonclinical settings (such as schools). Importantly, cutoff scores to 
determine ‘caseness’ varied widely, and no single score was identified to be applicable in 
both clinical and community settings, for any scale. However, metaregression revealed that 
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studies using higher cutoff scores on the CES-D had higher diagnostic accuracy (AUC) than 
those with lower scores. Regardless, if researchers or clinicians choose to employ cutoff 
scores on commonly used symptom screening scales for MDD to determine clinical 
‘caseness’, they will most likely need to be adjusted to suit the sample under investigation.  
 
Limitations 
There are several limitations to consider when interpreting the outcomes of this review. 
Firstly, risk of bias for the included studies was largely unable to be determined, or 
determined to be high due to insufficient reporting. Secondly, many studies adjusted the 
cutoff score to determine clinical caseness post hoc in order to maximise sensitivity and 
specificity values, which may have artificially increased the diagnostic accuracy results using 
AUC analyses, as these values are based on a trade off of sensitivity and specificity. 
Consequently, the results regarding diagnostic utility identified in this review may differ in 
real world settings where specific cutpoints are typically chosen a priori to classify 
participants as having clinically significant depressive symptoms. Further, such cutpoints are 
likely to vary substantially on a study by study basis and depending on the context in which 
the scale is used (e.g. schools versus clinics). Thirdly, positive and negative predictive values 
are dependent on the prevalence of the disorder in the sample (Trikalinos et al., 2012), and as 
such, the low positive predictive values identified in this review may reflect a low prevalence 
of depression among some samples; however the small number of studies and significant 
heterogeneity between them precluded the use of metaregression to determine factors which 
may have influenced predictive power in this review. Where metaregression was conducted, 
it is possible that some analyses were underpowered due to low numbers of studies with 
adequate data, as evidenced by low adjusted R2 values for some outcomes. A greater number 
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of high quality studies examining the psychometric properties of these scales across a range 
of settings and ages is needed in in order to identify circumstances in which performance of 
these scales is likely to differ. Further, while our review considered internal reliability of the 
scales, other measures of reliability that may impact scale utility, including test retest and 
inter rater reliability were less consistently reported, precluding the conduct of meta analyses 
and metaregression on these outcomes. Finally, it is also important to consider that while the 
criterion standards employed throughout this review (i.e. diagnostic interview schedules 
based on DSM or ICD-10 diagnostic criteria such as the K-SADs) are currently the gold 
standard in detecting the presence of a depressive disorder (Carlisle and McClellan, 2009), 
they are not perfect measures, and are also open to the same issues of reliability and validity 
as the screening scales themselves (Hodges, 1993).  
There has been recent criticism of binary classification systems such as the DSM, which take 
the assumption that people should be classified as either having or not having a particular 
psychopathological disorder (Hankin et al., 2005), with suggestions that depression may 
occur on a continuum (Solomon et al., 2001), particularly so in youth (Hankin et al., 2005). In 
light of this, other outcomes in depression treatment that take into account the disability 
caused by the disorder have been considered, such as functional impairment (McKnight and 
Kashdan, 2009). Recent research suggests that indicators of disability or functional 
impairment, in the absence of a formal diagnosis of a mental disorder may be a useful 
measure of need for mental health services and treatment. An analysis of the 2007 Australian 
Survey of Mental Health and Wellbeing found that a significant proportion of those who had 
used mental health services in the past 12 months did not have a formally diagnosed mental 
disorder, but had other indicators of possible need, including maintenance treatment 
following a previous episode or significant psychological distress in the absence of a 
diagnosis (Harris et al., 2014). Thus, in addition to using classification systems such as ICD 
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and DSM to determine mental disorder diagnoses  and symptom screening scales to measure 
symptom severity, researchers examining the efficacy of  depression prevention and 
treatment interventions should also consider including items assessing functional impairment, 
as this may be a useful indicator of disability and need for treatment, even if a formal mental 
diagnosis is not given (Üstün and Kennedy, 2009).  
While there has been some suggestion that routine screening of MDD symptoms may 
improve the detection of, and initiate timely treatment for MDD among children and 
adolescents at a population level (Thombs et al., 2012), the impact of routine screening for 
MDD on health outcomes for children and adolescents is unclear (Williams et al., 2009), and 
there is some concern that screening may have the potential to cause harm to those who may 
be diagnosed and treated inappropriately (MacMillan et al., 2005). Reviews conducted by the 
Canadian Task Force on Preventive Health Care, and  the United Kingdom’s National 
Institute of Health and Clinical Excellence both concluded that there was insufficient 
evidence regarding health outcomes to support the routine screening of MDD among children 
and adolescents in primary healthcare settings (MacMillan et al., 2005, National 
Collaborating Centre for Mental Health, 2005). Unfortunately there have been few large 
prospective cohort studies that have examined the ability of MDD screening scales in 
predicting the onset of depression among adolescents in order to inform their routine use in 
healthcare settings (van Lang et al., 2007). Interestingly such studies have indicated that 
recurrent screening of depressive symptoms does not improve detection of MDD, but that 
cognitive and physical symptoms (such as sleeping problems) may be better predictors. 
(McKenzie et al., 2011, van Lang et al., 2007). For example, McKenzie et al, 2011 identified 
that particular items of the Short Mood and Feelings Questionnaire (SMFQ) that are not 
included in formal diagnostic criteria for MDD, such as “I hated myself” were most 
predictive of high depressive symptoms 12 months later. Such single items may have utility 
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for being incorporated into short screening measures, or existing population level surveys -  
many of which exclude mental disorder symptomatology (Baxter et al., 2013), however 
further research using large cohort studies is needed to support this.  
 
Conclusions  
Symptom screening scales for MDD are reliable measures of MDD symptomatology among 
adolescent samples. While we found that the psychometric properties of the scales did not 
differ when used in clinical and nonclinical settings, across a range of subject ages and with 
variable study quality, limited data was available, and further high quality studies are needed 
to identify conditions in which test performance may vary. Cutoff scores on symptom 
screening scales for MDD may be useful for identifying ‘risk status’, however, the cutoffs 
used will likely vary depending on the context in which the scale is applied, and 
misclassification is likely to be high, particularly in nonclinical samples where disorder 
prevalence is low (e.g. school settings).Further research examining the predictive ability of 
depression screening scales in cohort studies of children and adolescents are needed.  
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Table 1. Validation evidence for the Children’s Depression Inventory (CDI) in child and 
adolescent samples  
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AU
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Clinical              
Allgaier et 
al. 2012 
40
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9-12  
(56, 
44) 
 
Child hospital 
patients 
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CDI 
(27) 
 
α = 0.84 
 
Kinder-
DIPS 
≥ 12 
 
0.83 
 
0.83 
 
0.2
8 
 
0.9
8 
 
 
0.8
8 
 
Figueras  
Masip et 
al. 2010a 
10
2 
10-
18 
(41, 
59) 
Child and 
adolescent 
clinical sample  
(Spain) 
CDI 
(27) 
α = 0.85 
 
Clinical 
intervie
w  
19 0.95 0.96 - - - 
Roelofs et 
al. 2010 
51
1 
7-18 
(52, 
48)  
Child and 
adolescent 
clinical sample 
(Belgium) 
CDI 
(27) 
 - KID-
SCID 
16 0.92 0.95 0.3
5 
1.0
0 
0.9
5 
Shemesh et 
al. 2005 
81 8-19  
(42, 
58) 
Child and 
adolescent 
hospital 
patients 
(USA)  
CDI 
(27) 
 - K-
SADS-
PL  
11 0.80 0.70 0.3
8 
0.9
4 
- 
Sorensen 
et al. 2005  
14
9 
8-13  
 
Child and 
adolescent 
psychiatric 
patients 
(Denmark) 
CDI 
(27) 
α = 0.86 
 
K-
SADS-
PL 
12 0.63 0.64 0.2
1 
0.6
3 
0.7
2 
Timbremo
nt et al. 
2004  
80 8-18 
(42, 
58) 
Child and 
adolescent 
psychiatric 
inpatients/outp
atients, 
(Belgium, 
Netherlands) 
CDI 
(27) 
κ = 
0.76  
KID-
SCID 
16 0.84 0.94 0.6
3 
0.9
8 
0.8
6 
Craighead 
et al. 1995 
10
7 
12-
18 
(54, 
46) 
Child and 
adolescent 
psychiatric 
inpatients 
(USA) 
CDI 
(27) 
- K-
SADS-
III-R 
17 0.81 0.84 - - - 
Weiss et 
al. 1991a 
51
5 
8-12 
(73, 
27) 
Child in- and 
out- patients 
CDI 
(27) 
α = 0.86 
 
- - - - - - - 
Weiss et 
al. 1991b 
76
8 
13-
16 
(52, 
48) 
Adolescent in- 
and out- 
patients 
CDI 
(27) 
α = 0.88 - - - - - - - 
Nelson III 
and 
Politano 
1990 
96 6-15 
(61, 
39) 
Child and 
adolescent 
psychiatric 
inpatients 
(USA) 
CDI 
(27) 
Test-
retest: 
0.62 
- - - - - - - 
Fristad et 
al. 1988 
 98 6-13 Child and 
adolescent 
depressed 
inpatients, 
psychiatric 
inpatient 
controls, 
 CD
I 
(27) 
 -  DICA ≥15 0.89 0.65 0.9
0 
- - 
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normal 
controls (USA) 
Carey et al. 
1987a 
15
3 
9-17 
(75, 
25) 
Child and 
adolescent 
inpatients 
(USA) 
CDI 
(27) 
α = 0.83 - - - - - - - 
Nelson III 
et al. 1987 
53
5 
6-17 
(68, 
32) 
Child and 
adolescent 
psychiatric 
inpatients 
(USA) 
CDI 
(27) 
α = 0.86 - - - - - - - 
Saylor et 
al. 1984a 
10
5 
7-16 
(69, 
31) 
Child and 
adolescent 
inpatients 
(USA) 
 CD
I 
(27) 
Kuder-
Richard
son 
coeffici
ent= 
0.80 
- - - - - - - 
Non-
Clinical 
            
Thompson 
et al. 2012 
19
1 
11-
17 
(53, 
47) 
Child and 
adolescent 
sample with 
inflammatory 
bowel disease 
(USA) 
CDI 
(27) 
α = 0.88 - - - - - - - 
Figueras 
Masip et 
al. 2010b 
17
05  
 
 10-
18 
(46, 
54) 
Child and 
adolescent 
community 
sample 
(Spain)  
CDI 
(27) 
α = 0.82 
Test-
retest = 
0.81 
 - - - - - - - 
Giannakop
oulos et al. 
2009  
53
8 
 8-12 
(47, 
53) 
Child nation-
wide school-
based sample 
(Greece) 
CDI 
(27) 
α= 0.80;  
test-
retest 
reliabilit
y ICC: 
0.82 for 
girls 
and 
0.62 for 
boys 
- ≥ 15 - - - - - 
Crowley 
and 
Emerson 
1996 
27
3 
8-12 
(51, 
49) 
Child school 
students 
(USA) 
CDI 
(27) 
α = 0.89 - - - - - - - 
Crowley et 
al. 1994 
16
4 
11-
16 
(49, 
51) 
Child and 
adolescent 
community 
sample 
(USA) 
CDI 
(27) 
α = 0.86 - - - - - - - 
Fundudis 
et al. 1991 
93 8-16 
(50, 
50)  
Children and 
adolescents of 
staff of a 
university 
child 
psychiatry 
department 
(USA) 
CDI 
(27) 
α = 0.88 Standard
ised 
Psychiat
ric 
Intervie
w 
15 0.77 0.77 - - - 
Carey et al. 
1987b 
15
3 
9-17 
(74, 
26) 
Child and 
adolescent 
non-referred 
sample 
CDI 
(27) 
α = 0.75 - - - - - - - 
Finch et al. 
1987 
10
8 
7-12 
(51, 
49) 
Child sample 
from public 
schools 
(USA) 
CDI 
(27) 
Test-
retest: 
0.82 
- - - - - - - 
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Smucker et 
al. 1986 
12
52 
8-16 
(47, 
53)  
Child and 
adolescent 
sample from 
public schools 
(USA) 
CDI 
(27) 
α = 0.89  - - - - - - - 
Reynolds 
et al 1985 
16
6 
8-12 
(46, 
54)  
Child sample 
from public 
schools  
(USA)  
CDI 
(27) 
α = 0.90  - - - - - - - 
Saylor et 
al. 1984b 
72 10-
13 
(31, 
69) 
Child sample 
from public 
schools  
(USA) 
CDI 
(27) 
Kuder-
Richard
son 
coeffici
ent= 
0.94 
- - - - - - - 
Note:  
N = Number of participants in the study sample 
PPV = Positive predictive value 
NPV = Negative predictive value 
AUC = Area under the curve analysis 
CDI = Children’s Depression Inventory  
α = Cronbach’s alpha reliability co-efficient 
κ = Cohen’s kappa reliability co-efficient 
Kinder-DIPS: The Diagnostic Interview for Psychiatric Disorders in Children and Adolescents 
KID-SCID: The child version of the Structured Clinical Interview for DSM Disorders 
K-SADS-PL: The Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime version 
K-SADS-E: The Schedule for Affective Disorders and Schizophrenia for School-Age Children – Epidemiological Version 
K-SADS-III-R: The Schedule for Affective Disorders and Schizophrenia for School-Age Children – the revision of the third edition 
DICA: The Diagnostic Interview for Children and Adolescents 
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Table 2. Validation evidence for the Beck Depression Inventory (BDI) in child and 
adolescent samples 
Source N Age & 
Gender 
(%m, 
%f) 
Sample 
(location
) 
Scal
e 
nam
e 
(no. 
of 
item
s) 
Reliabil
ity 
Criterion Cuto
ff 
Sensitiv
ity 
Specific
ity 
PP
V 
NP
V 
A
U
C 
Clinic
al 
            
Dolle et 
al. 2012 
88 13-16 Adolesce
nt 
psychiatr
ic 
patients 
(German
y) 
BDI-
II 
(21) 
α = 0.94 Kinder-
DIPS 
 
≥23 0.88 0.92 0.8
1 
0.95 0.9
3 
Blom et 
al. 2010 
73 14-18 
(0, 100) 
Adolesce
nt girls 
who 
were 
psychiatr
ic 
patients 
(Sweden
) 
BDI-
A1 
(21) 
- DAWBA >14 - - - - 0.8
6 
Krefetz 
et al. 
2002 
10
0 
12-17 
(44, 56) 
Child 
and 
adolesce
nt 
psychiatr
ic 
inpatient
s 
(USA) 
BDI-
II 
(21) 
α = 0.92 PRIME-
MD 
24 0.74 0.70 0.7
6 
0.67 0.7
8 
Kumar 
et al. 
2002 
10
0 
12-17 
(45, 55) 
Child 
and 
adolesce
nt 
psychiatr
ic 
inpatient
s 
(USA) 
BDI-
II 
(21) 
α = 0.94 PRIME-
MD 
21 0.85 0.83 0.8
5 
0.83 0.9
2 
Bennett 
et al. 
1997 
32
8 
11-19 
(41.5, 
58.5) 
Child 
and 
adolesce
nt 
psychiatr
ic 
inpatient
s and 
outpatien
ts of a 
clinic for 
depressi
on 
(USA) 
BDI 
(21) 
- K-SADS 13 0.87 0.71 0.8
1 
0.80 - 
Jolly et 
al. 1994 
75 12-17 
(47, 53) 
Child 
and 
adolesce
nt 
inpatient
BDI 
(21) 
α = 0.88 - - - - - - - 
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s (USA) 
Ambros
ini et 
al. 1991 
12
2 
12-19 
(43, 57) 
Child 
and 
adolesce
nt 
outpatien
ts 
referred 
to a 
clinic for 
depressi
on 
(USA) 
BDI 
(21) 
α = 0.91 K-SADS-
III-R 
16 0.86 0.82 0.9
3 
- - 
Marton 
et al, 
1991 
11
9 
14-19 
(42.9; 
57.1) 
Adolesce
nt 
inpatient
s and 
outpatien
ts of a 
children'
s mental 
health 
centre 
with a 
current 
DSM-III 
Axis I 
psychiatr
ic 
disorder 
(Depress
ed, n = 
60 vs 
Non-
Depresse
d, n = 
59; 
USA) 
BDI 
(21) 
- DICA 16 0.68 0.81 0.7
9 
- - 
Barrera 
and 
Garriso
n-Jones 
1988a 
65 12-17 
(48,52) 
Child 
and 
adolesce
nt 
psychiatr
ic 
inpatient
s (USA) 
BDI 
(21) 
α = 0.86 CAS 11 0.82 0.53 - - - 
Strober 
et al. 
1981 
78 12-16 
(46, 54) 
Child 
and 
adolesce
nt 
patients 
(USA) 
BDI 
(21) 
α = 0.79 SADS 16 0.81 0.81 - - - 
Non-Clinical             
Russell 
et al. 
2012 
18
1 
14-17 Adolesce
nts from 
three 
schools 
(India) 
BDI 
(21) 
κ = 0.06 K-SADS-
PL 
18 0.63 0.70 0.1
4 
0.97 0.6
7 
Adewu
ya et al. 
2007 
10
95 
13-18 
(58, 42) 
Adolesce
nts 
attending 
secondar
y school 
(Nigeria) 
BDI 
(21) 
α = 0.82 K-SADS-
E 
18 0.91 0.97 0.8
8 
 
0.98 0.9
9 
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Canals 
et al. 
2001 
30
4 
17.5-
18.5 
(50.3,49.
7) 
Adolesce
nts from 
an urban 
commerc
ial area 
(Spain) 
BDI 
(21) 
- SCAN 16 0.90 0.96 0.4
7 
0.99 - 
Roberts 
et al. 
1991a 
17
10 
14-18 
(47, 53) 
Adolesce
nts from 
senior 
high 
schools 
(USA) 
BDI 
(21) 
α = 0.88 K-SADS 11 0.84 0.81 0.1
0 
0.99
5 
- 
Roberts 
et al. 
1991b  
80
4 
14-18 
(100,0) 
Male 
adolesce
nt 
sample 
from 
senior 
high 
schools 
(USA) 
BDI 
(21) 
- K-SADS 15 - - - - 0.9
3 
Roberts 
et al. 
1991c 
90
6 
14-18 
(0,100) 
Female 
adolesce
nt 
sample 
from 
senior 
high 
schools 
(USA) 
BDI 
(21) 
- K-SADS 11 - - - - 0.8
3 
Kashan
i et al. 
1990 
10
2 
13-18 
(53, 47) 
Adolesce
nts who 
attended 
an 
outpatien
t 
“counsel
ling 
center” 
(USA) 
BDI 
(21) 
α = 0.87 DICA 16 0.48 0.87 - - 0.7
9 
Whitak
er et al 
1990 
35
6 
14-17 
(45.8; 
45.5) 
Adolesce
nts 
(grades 
8-12) 
from 8 
schools 
in New 
Jersey 
county 
(USA) 
BDI 
(21) 
- Semi-
structured 
clinical 
interview 
based on 
DSM-III 
criteria 
administer
ed by 
child 
psychiatri
st or 
health 
profession
al 
16 0.80 0.65 - - - 
Barrera 
and 
Garriso
n-Jones 
1988b 
49 12-18 
(45; 55) 
Child 
and 
adolesce
nt 
secondar
y school 
students 
(USA) 
BDI 
(21) 
α = 0.90 CAS 16 1.00 0.93 - - - 
Teri 
1982 
56
8 
14-17 
(40, 60) 
High 
school 
students 
(USA) 
BDI 
(21) 
α = 0.87 - - - - - -  
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Note: 
N = Number of participants in the study sample 
PPV = Positive predictive value 
NPV = Negative predictive value 
AUC = Area under the curve analysis 
BDI = Beck Depression Inventory  
α = Cronbach’s alpha reliability co-efficient 
κ = Cohen’s kappa reliability co-efficient 
Kinder-DIPS: The Diagnostic Interview for Psychiatric Disorders in Children and Adolescents 
DAWBA: The Development and Wellbeing Assessment 
PRIME-MD: The Primary Care Evaluation of Mental Disorders 
K-SADS: The Schedule for Affective Disorders and Schizophrenia for School-Age Children  
K-SADS-III-R: The Schedule for Affective Disorders and Schizophrenia for School-Age Children – the revision of the third edition 
CAS: The Child Assessment Schedule 
SADS: The Schedule for Affective Disorders and Schizophrenia 
K-SADS-PL: The Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime version 
K-SADS-E: The Schedule for Affective Disorders and Schizophrenia for School-Age Children – Epidemiological Version 
DICA: The Diagnostic Interview for Children and Adolescents 
SCAN: Schedules for Clinical Assessment in Neuropsychiatry 
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Table 3. Validation evidence for the Center for Epidemiologic Studies Depression Scale 
(CES-D) in child and adolescent samples 
Source N Age 
& 
Gend
er 
(%m, 
%f) 
Sample 
(location) 
Scal
e 
nam
e  
(no. 
of 
item
s) 
Reliabil
ity 
Criteri
on 
Cuto
ff 
Sensitiv
ity 
Specific
ity 
PP
V 
NP
V 
AU
C 
Clinical             
Logsdon 
and Myers 
2010 
5
9 
13-18 
(0, 
100) 
Adolescen
t mothers 
at 4-6 
weeks 
postpartu
m 
(USA) 
CES
-D  
(20) 
α = 0.84 K-
SADS-
PL 
16 0.7 0.52 0.2
5 
0.1
2 
0.62 
Aebi et al. 
2009 
1
4
0 
Mean: 
15.5 
(33, 
67) 
Adolescen
ts 
diagnosed 
with major 
depressive 
disorders 
(Switzerla
nd) 
CES
-D 
(20) 
α = 0.83 Clinical 
intervie
w 
21 0.86 0.86 - - 0.94 
Non-
Clinical 
            
Betancourt 
et al. 2012 
3
6
7 
10-17 
(33, 
67) 
Children 
and 
adolescent
s 
(Rwanda) 
CES
-DC 
(20) 
α = 0.86 MINI-
KID 
≥30 0.82 0.72 - - 0.83 
Cuijpers et 
al. 2008 
1
3
9
2 
14-16 
(52, 
48) 
Adolescen
ts 
(Netherlan
ds) 
CES
-D 
(20) 
α = 0.93 MINI 22 0.9 0.74 - - 0.90 
Thrane et 
al. 2004 
2
1
3 
9-16 
(54, 
46) 
Adolescen
ts from 
three 
American 
Indian 
reservation
s 
(USA) 
CES
-D 
(20) 
α = 0.80 - 
 
- - - - - - 
Yang et al. 
2004 
2
4
4
0 
12-16 
(52, 
48) 
Adolescen
ts 
(Taiwan) 
CES
-D 
(20) 
α = 0.9 K-
SADS-
E 
90th 
%tile 
0.41 0.9 - - 0.9 
Prescott et 
al. 1998 
5
5
6 
Mean: 
16.8 
Adolescen
t students 
from 
grades 9-
12 (USA) 
CES
-D 
(20) 
- DISC 16 0.79 0.74 0.2
4 
0.9
6 
0.74 
Garrison et 
al. 1991a 
1
2
3
1 
12-14 
(100, 
0) 
Child and 
adolescent 
boys from 
school 
sample  
(USA) 
CES
-D 
(20) 
α = 0.81 K-
SADS-
P 
12 0.85 0.49 0.1
6 
0.9
8 
0.61 
Garrison et 
al.1991b 
1
2
3
4 
12-14 
(0, 
100) 
Child and 
adolescent 
girls from 
a school 
CES
-D 
(20) 
α = 0.86 K-
SADS-
P 
22 0.83 0.77 0.3
2 
0.9
8 
0.77 
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sample  
(USA) 
Roberts et 
al. 1991a 
1
7
1
0 
14-18 
(47, 
53) 
Adolescen
ts of nine 
senior 
high 
schools 
(USA) 
CES
-D 
(20) 
α = 0.89 K-
SADS 
24 0.84 0.75 0.0
8 
0.9
9 
- 
  
Roberts et 
al. 1991b  
8
0
4 
14-18 
(100,0
) 
Adolescen
t male 
sample of 
nine senior 
high 
schools 
(Roberts et 
al, 1991a; 
USA) 
CES
-D 
(20) 
- K-
SADS 
22 - - - - 0.87 
Roberts et 
al. 1991c 
9
0
6 
14-18 
(0,100
) 
Adolescen
t female 
enrolment 
of nine 
senior 
high 
schools 
(Roberts et 
al, 1991a; 
USA) 
CES
-D 
(20) 
- K-
SADS 
24 - - - - 0.83 
Fendrich et 
al. 1990 
2
2
0 
12-18 Children 
and 
adolescent
s at risk 
for 
depression 
according 
to their 
parents’ 
diagnosis 
(USA) 
CES
-DC 
(20) 
α = 0.89 K-
SADS-
E 
≥16 0.71 0.62 0.1
5 
0.9
6 
- 
 
Note:  
N = Number of participants in the study sample 
PPV = Positive predictive value 
NPV = Negative predictive value 
AUC = Area under the curve analysis 
CES-D = Center for Epidemiologic Studies Depression Scale  
CES-DC = Center for Epidemiologic Studies Depression Scale Child Version 
α = Cronbach’s alpha reliability co-efficient 
K-SADS-PL: The Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime version 
MINI-KID: The Mini-International Neuropsychiatric Interview 
MINI: The Mini-International Neuropsychiatric Interview for children 
K-SADS: The Schedule for Affective Disorders and Schizophrenia for School-Age Children  
K-SADS-E: The Schedule for Affective Disorders and Schizophrenia for School-Age Children – Epidemiological version 
DISC: The National Institute of Mental Health Diagnostic Interview Schedule for Children 
K-SADS-P: The Schedule for Affective Disorders and Schizophrenia for School-Age Children Present Episode version 
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Table 4. Validation evidence for the Reynolds Adolescent Depression Scale (RADS) in child 
and adolescent samples 
Source N Age 
& 
Gend
er 
(%m, 
%f) 
Sample 
(location) 
Scale 
name 
(no. 
of 
items
) 
Reliabili
ty 
Criteri
on 
Cuto
ff 
Sensitivi
ty 
Specifici
ty 
PP
V 
NP
V 
AU
C 
Clinic
al 
            
Osman, 
A. et al. 
2010 
196 14-17 
(43, 
57) 
Adolescen
t 
inpatients 
(USA) 
RAD
S-2 
(30) 
α = 0.95 BHS 67 0.64 0.8 0.7
7 
0.6
8 
0.80 
Krefetz 
et al. 
2002 
100 12-17 
(44, 
56) 
Child and 
adolescent 
psychiatri
c 
inpatients 
(USA) 
RAD
S 
(30) 
α = 0.91 PRIME
-MD 
70 0.86 0.49 0.6
9 
0.7
2 
0.76 
Non-
Clinic
al 
            
Weber 
and 
Terhors
t 2010 
265 13-18 
(73, 
27) 
Adolescen
t LGBTIQ 
youth 
(USA) 
RAD
S-2 
(30) 
α = 0.92 - - - - - - - 
Walker 
et al. 
2005 
969
9 
12-18 
(46, 
54) 
Child and 
adolescent 
school 
students 
(New 
Zealand) 
RAD
S 
(30) 
α = 0.94 - - - - - - - 
Boyd et 
al. 1997 
783 11-18 
(49, 
52) 
Child and 
adolescent 
school 
students 
(Australia
) 
RAD
S 
(30) 
α = 0.85 - - - - - - - 
Reynol
ds & 
Miller 
1985a 
26 Mean: 
17.3 
Intellectua
lly 
delayed 
adolescent 
school 
students 
(USA) 
RAD
S 
(30) 
α = 0.87 - - - - - - - 
Reynol
ds & 
Miller 
1985b 
26 Mean: 
16.7 
Non-
intellectua
lly 
delayed 
adolescent 
school 
students  
(USA) 
RAD
S 
(30) 
α = 0.97 - - - - - - - 
Note: 
N = Number of participants in the study sample 
PPV = Positive predictive value 
NPV = Negative predictive value 
AUC = Area under the curve analysis 
RADS = Reynolds Adolescent Depression Scale  
α = Cronbach’s alpha reliability co-efficient 
BHS: Beck Hopelessness Scale 
PRIME-MD: The Primary Care Evaluation of Mental Disorders 
LGBTIQ: Lesbian, Gay, Bisexual, Transgender, Intersexual, Questioning.  
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Highlights:  
• Symptom screening scales are often used to determine a clinical diagnosis of 
depression. 
• We examined the diagnostic utility of these scales using systematic review and meta-
analysis.   
• Commonly used screening scales for depression are reliable measures among 
adolescents.  
• Using cutpoints to determine a clinical diagnosis may produce high misclassification 
rates.  
 
  
